Edition:
India

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

209.79USD
21 Feb 2018
Change (% chg)

$1.95 (+0.94%)
Prev Close
$207.84
Open
$208.30
Day's High
$213.51
Day's Low
$208.30
Volume
358,733
Avg. Vol
454,593
52-wk High
$226.34
52-wk Low
$151.76

Latest Key Developments (Source: Significant Developments)

Thermo Fisher Scientific Sees FY 2018 Revenue Between $23.42 Bln To $23.72 Bln
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Thermo Fisher Scientific Inc ::SEES FY 2018 REVENUE BETWEEN $23.42 BILLION TO $23.72 BILLION.FY2018 REVENUE VIEW $23.00 BILLION -- THOMSON REUTERS I/B/E/S.SEES FY 2018 ADJUSTED EPS IN RANGE OF $10.68 TO $10.88.FY2018 EARNINGS PER SHARE VIEW $10.63 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 ORGANIC REVENUE GROWTH BETWEEN 4 PERCENT AND 5 PERCENT: CONF CALL.SAYS ASSUMING FOREIGN EXCHANGE IS A $300 MILLION REVENUE TAILWIND FOR 2018: CONF CALL.SAYS EXPECTS ACQUISITIONS COMPLETED IN 2017 WILL CONTRIBUTE 7 PERCENT TO ITS REPORTED REVENUE GROWTH IN 2018: CONF CALL.SAYS ASSUMING NET CAPITAL EXPENDITURES TO BE ABOUT $700 MILLION TO $730 MILLION FOR 2018: CONF CALL.CEO SAYS WILL CONTINUE TO PAY ATTENTION TO THREAT TO ITS BUSINESS FROM AMAZON; SAYS FEELS GOOD ABOUT CO'S COMPETITIVE POSITION.  Full Article

Thermo Fisher Increases Quarterly Dividend to $0.17 Per Common Share
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC INC - BOARD AUTHORIZED QUARTERLY CASH DIVIDEND OF $0.17 PER COMMON SHARE, UP 13 PERCENT.  Full Article

Thermo Fisher To Invest $50 Mln Due to Benefit Of Tax Reform Legislation In U.S.
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC INC - TO MAKE ADDITIONAL INVESTMENTS OF $50 MILLION AS RESULT OF BENEFIT OF FEDERAL TAX REFORM LEGISLATION IN U.S..THERMO FISHER SCIENTIFIC INC - INVESTMENTS INCLUDE $34 MILLION FOR ONE-TIME BONUS OF $500 TO BE PAID TO ELIGIBLE NON-EXECUTIVE EMPLOYEES GLOBALLY.THERMO FISHER SCIENTIFIC INC - INVESTMENTS ALSO INCLUDE $16 MILLION TO ACCELERATE KEY BREAKTHROUGH RESEARCH AND DEVELOPMENT PROGRAMS, AND OTHER THINGS.  Full Article

Thermo Fisher Scientific Reports Q4 Shr of $1.30
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC INC - Q4 GAAP EARNINGS PER SHARE $1.30; Q4 ADJUSTED EARNINGS PER SHARE $2.79.THERMO FISHER SCIENTIFIC INC - REVENUE FOR Q4 GREW 22 PERCENT TO $6.05 BILLION IN 2017.THERMO FISHER SCIENTIFIC INC - 2017 GAAP RESULTS INCLUDE ONE-TIME TAX PROVISION OF $204 MILLION ASSOCIATED WITH TAX REFORM LEGISLATION IN THE U.S..  Full Article

Thermo Fisher Scientific Completes Acquisition of Phenom-World
Saturday, 30 Dec 2017 

Dec 29 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC - ‍WILL INTEGRATE PHENOM-WORLD​ BUSINESS INTO CO'S ANALYTICAL INSTRUMENTS SEGMENT; TERMS OF DEAL NOT DISCLOSED.THERMO FISHER SCIENTIFIC INC - ‍COMPLETED ACQUISITION OF PHENOM-WORLD​.  Full Article

Juno Therapeutics And Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Juno Therapeutics Inc ::JUNO THERAPEUTICS AND THERMO FISHER SCIENTIFIC ANNOUNCE CAR T MANUFACTURING PARTNERSHIP.JUNO THERAPEUTICS - OBTAINED RIGHTS TO USE CTS DYNABEADS CD3/CD28 MAGNETIC BEADS FOR CLINICAL, COMMERCIAL MANUFACTURING PROCESSES FOR CAR T THERAPIES.JUNO THERAPEUTICS INC - NO OTHER TERMS FROM THIS TRANSACTION WERE DISCLOSED.  Full Article

Thermo Fisher Scientific Acquires Continuous Emission Monitoring Assets From Eptek Technology
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC ACQUIRES CONTINUOUS EMISSION MONITORING ASSETS FROM EPTEK TECHNOLOGY.THERMO FISHER SCIENTIFIC INC - TERMS OF TRANSACTION WERE NOT DISCLOSED.​.  Full Article

Evoke Pharma signs commercial agreement with Thermo Fisher Scientific
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Evoke Pharma Inc ::Signs commercial agreement with Thermo Fisher Scientific.Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​.Under five-year agreement, Thermo Fisher will manufacture Gimoti for Evoke's potential commercial efforts​.  Full Article

Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Cellular Biomedicine Group Inc :Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes.Cellular Biomedicine Group Inc - ‍partnership focuses on research and development of an automated cell therapy manufacturing system​.  Full Article

Thermo Fisher enters agreement with Blueprint Medicines​
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Thermo Fisher Scientific Inc TMO.N:Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​.Thermo Fisher Scientific - co will retain rights to commercialize test globally, to lead necessary filings to seek clearance from regulatory agencies.Thermo Fisher Scientific Inc - ‍agreement to develop and commercialize Oncomine Dx Target Test as a companion diagnostic for BLU-667​.  Full Article

BRIEF-OncoTherapy Science unit says business alliance with Thermo Fisher Scientific

* Says its unit, Cancer Precision Medicine forms business alliance with Thermo Fisher Scientific